RxAnte
PrivateLast Round
Private Equity
Jan 12, 2026
Total Funding Raised
$19.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RxAnte is a healthcare technology systems company that provides predictive analytics and targeted clinical programs intended to improve medication prescribing and adherence.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Vertical SaaS, Patient Engagement, Medical AI, Workflow Automation
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RxAnte Comparables
Compare RxAnte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AdhereHealth | 91% | |
| Arine | 82% | |
| AssistRx | 78% | |
RxAnte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jan 12, 2026 | ||||
| Debt | Dec 20, 2022 | ||||
| Growth Equity | Oct 5, 2016 | ||||
| Series A | Sep 1, 2012 |
RxAnte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PNC Erieview Capital | Private Equity |
| Primus Capital Partners | Private Equity |
| Aberdare Ventures | Series A |
| Trinity Capital | Debt |
| UPMC Enterprises | Private Equity, Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
Primus Capital Partners led the round with UPMC Enterprises and PNC Erieview Capital also participating.
- May 1, 2025
Monthly visitors grew 166% MoM, reaching 33K.
RxAnte Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RxAnte's valuation, stock price, and market status.